UICC World Cancer Congress 2006

Objective: The purpose of this descriptive, retrospective study was to determine QOL and symptom concerns in a cohort of lung cancer patients treated at a NCI designated comprehensive cancer center. The study aims were to describe 1)treatment received by lung cancer patients consistent with NCCN guidelines; and 2) symptoms experienced by lung cancer patients impacting QOL.

Methods: Fifty four patients were selected by the tumor registry from the 150 new lung cancer patients seen over a 12 month period. A detailed audit tool reflecting aspects of quality care as described by the NCCN was developed, peer reviewed and tested to establish reliability. The care for each patient was audited for a 6 month period to capture all encounters. Descriptive statistics were used to analyze the data.

Results: Eighty five per cent of patients had stage III-IV disease and 78% had comorbidities. Eighty three percent received chemotherapy and 35% radiation therapy. Pain, dyspnea, cough, and weight loss were the most reported symptoms. Major deficits were identified in care when compared to NCCN guidelines as only 30% of patients had advanced directives and 32% received no supportive care services (e.g. pain consult, social work, nutrition services). Uncontrolled symptoms were a common reason for outpatient visits with pain, dyspnea and fatigue as the most common symptoms. Symptoms accounted for 38% of hospital readmissions. This study serves to guide the institution in development of more effective support services for patients with lung cancer to address QOL concerns through collaboration between clinicians and researchers in the cancer center.